Patents by Inventor Max Everett Distler

Max Everett Distler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260199451
    Abstract: The present disclosure provides, for example, vaccine compositions comprising an mRNA molecule and a double stranded DNA molecule. The DNA molecule may be hemi-modified. The mRNA molecule and DNA molecule may encode the same or similar immunogen. In some embodiments, the combination of the mRNA molecule and the DNA molecule evokes a stronger immune response than either one alone. Methods of making and using the vaccine compositions are also described.
    Type: Application
    Filed: January 8, 2026
    Publication date: July 16, 2026
    Inventors: Jacob Rosenblum Rubens, Louisa Marie Helms, Max Everett Distler, Edward Matthew Kennedy
  • Publication number: 20260199516
    Abstract: The disclosure provides, for example, a targeted lipid nanoparticle composition comprising a lipid nanoparticle, a targeting moiety on the surface of the lipid nanoparticle, wherein the targeting moiety binds a T cell antigen, and a double stranded DNA molecule comprising an effector sequence that encodes an effector. In some embodiments, the targeting moiety comprises an antibody. In some embodiments, the effector comprises a polypeptide. In some embodiments, the double stranded DNA molecule comprises chemically modified nucleobases in its sense strand, and the antisense strand is free of chemically modified nucleobases.
    Type: Application
    Filed: January 8, 2026
    Publication date: July 16, 2026
    Inventors: Louisa Marie Helms, Max Everett Distler, Brian Patrick Mead, Edward Matthew Kennedy
  • Publication number: 20250043081
    Abstract: The present disclosure is directed to multicomponent assemblies (e.g., crystalline structures) using oligonucleotide dendrimers and spherical nucleic acids (SNAs). The disclosure also provides methods of forming the multicomponent assemblies.
    Type: Application
    Filed: December 5, 2022
    Publication date: February 6, 2025
    Inventors: Chad A. Mirkin, Max Everett Distler, Ho Fung Cheng, Kyle Joseph Gibson
  • Publication number: 20230382941
    Abstract: The present disclosure is directed to spherical nucleic acids (SNAs) comprising a nanoparticle core and an oligonucleotide dendron attached thereto. The disclosure also provides methods of using the SNAs for, for example, gene regulation and immune regulation.
    Type: Application
    Filed: July 24, 2023
    Publication date: November 30, 2023
    Inventors: Chad A. Mirkin, Katherine E. Bujold, Max Everett Distler
  • Publication number: 20220288181
    Abstract: Spherical Nucleic Acids (SNAs) are chemically well-defined nanoscale architectures comprised of nucleic acids densely arranged around a spherical nanoparticle core in a highly oriented fashion. SNAs are highly modular structures produced by chemical synthesis and programmed assembly, allowing for their rapid modification to incorporate novel viral antigens. The present disclosure provides a SNA comprising (a) a nanoparticle core; (b) a shell of oligonucleotides attached to the external surface of the nanoparticle core, the shell of oligonucleotides comprising one or more immunostimulatory oligonucleotides; and (c) a viral antigen encapsulated in the nanoparticle core.
    Type: Application
    Filed: March 1, 2022
    Publication date: September 15, 2022
    Inventors: Chad A. Mirkin, Michelle Hope Teplensky, Max Everett Distler, Caroline Danielle Kusmierz, Cassandra Elizabeth Callmann